Deployment and Upgrades for Pharmacoeconomics Quality Documentation

Pharmacoeconomics documentation typically includes clinical trial reports, real-world data (RWD/RWE), post-market surveillance data, medical insurance

Data Characteristics

Pharmacoeconomics documentation typically includes clinical trial reports, real-world data (RWD/RWE), post-market surveillance data, medical insurance policy documents, drug pricing strategies, and various cost-effectiveness analysis reports. Data update frequencies vary. Clinical trial data and medical insurance policies might update quarterly or semi-annually. Market pricing and drug usage data could update monthly. Document structures often mix structured data tables with unstructured text. For example, cost-effectiveness analysis reports contain detailed parameter tables, assumption descriptions, sensitivity analysis results, and extensive argumentative text. Fields involve drug generic names, indications, treatment plans, efficacy indicators (e.g., QALYs, LYG), cost components (direct, indirect), effect values, discount rates, and incremental cost-effectiveness ratios (ICER). Units include currency (e.g., CNY, USD), time (years, months, days), quantity (e.g., case count, treatment courses), and various ratios and percentages.

Constraints on Deployment and Upgrades

The mixed data structure of pharmacoeconomics documents imposes specific requirements on FastGPT deployment. Structured data requires precise field mapping and numerical parsing to accurately extract key indicators like costs and effects. Unstructured text relies on advanced semantic understanding and information extraction techniques to capture complex logic and arguments within reports. Inconsistent data update frequencies, especially dynamic changes in medical insurance policies and market pricing, demand an efficient incremental update mechanism for the knowledge base. This avoids resource waste and time delays from full re-indexing. Abundant specialized terminology and acronyms (e.g., QALY, ICER) challenge model domain adaptability, requiring more refined word embedding models and entity recognition configurations. Additionally, multilingual documents (e.g., original English with Chinese translation) may necessitate multilingual support or dedicated translation preprocessing.

Configuration Settings

Configuration ItemRecommended ValueRationale
Chunk size (Chunk Size)500–700 charactersPharmacoeconomics documents feature rigorous logical arguments. Increasing chunk size helps maintain contextual integrity and prevents truncation of critical information.
Recall count (Recall Count)Top 8–12 entriesComplex queries often involve multiple economic concepts and data points. Increasing recall count enhances the probability of retrieving highly relevant document chunks.
Similarity threshold (Similarity Threshold)0.75–0.82Ensures precision of recalled content, filtering out general medical or market information less relevant to pharmacoeconomics.
Rerank result count (Reranked Return Count)Top 5 entriesAfter processing by the reranking model, this focuses on the most relevant core information, improving response quality.
PARSE_FILE_TIMEOUT_SECONDS600 secondsLarge pharmacoeconomics reports (e.g., HTA reports) take longer to parse. Increasing the timeout prevents parsing interruptions.
VECTOR_DIMENSION768 or 1024To handle unique terminology and complex concepts in pharmacoeconomics, higher-dimensional vectors help capture semantic differences more finely.

Common Pitfalls

  • The knowledge base query returns too few results or content with low relevance. This typically results from a Similarity threshold (Similarity Threshold) set too high or Chunk size (Chunk Size) set too short. This prevents complete recall of key information or leads to insufficient semantic matching.
  • Document upload or parsing remains unresponsive for an extended period and eventually times out. This often occurs when the PARSE_FILE_TIMEOUT_SECONDS parameter is set too low. Large PDF or Word pharmacoeconomics reports cannot complete parsing within the default time.
  • After updating medical insurance policies or drug pricing data, AI responses fail to reflect the latest information. This may be due to not enabling incremental indexing or incorrect configuration of the incremental update trigger mechanism.

Verification Steps

  • Upload a typical pharmacoeconomics report. Use the knowledge base testing feature to check if Chunk size (Chunk Size) and Recall count (Recall Count) effectively capture key arguments and data tables within the report.
  • Simulate a query involving the latest medical insurance policies. Verify if the AI response accurately cites the updated policy terms. This confirms the effectiveness of the incremental update mechanism.
  • Conduct multi-turn dialogue tests. Ask complex questions about specific drug cost-effectiveness analysis or ICER value calculations. Observe if the AI provides logically clear and data-accurate answers based on the knowledge base content. Use this to evaluate the effectiveness of Similarity threshold (Similarity Threshold) and Rerank result count (Reranked Return Count).

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.